Work

Poster: CML-413 Efficacy and Safety of Bosutinib Versus Imatinib in US Patients With Newly Diagnosed Chronic Myeloid Leukemia After 5-Years Follow-Up in the

Year: 2022

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)00880-1

Authors: BFORE Trial Vamsi Kota, Michael W. Deininger, Jason Mendler, Wei Shen, Erinn Goldmann, Jorge E. Cortes

Institutions: University of Rochester Medicine, University of Rochester, Pfizer (United States)

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4296613074

FWCI:

Cites:

Cited by:

Related to: 10